NASDAQ : AUPH
Aurinia Pharmaceuticals Inc. — Financial statements
Healthcare · Biotechnology · Canada
Last price 16.65 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.22B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Aurinia Pharmaceuticals Inc. (AUPH) reported revenue of 321.74M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 321.74M | 283.06M | 235.13M | 175.51M | 134.03M | 45.60M |
| Cost of Revenue | 78.19M | 65.17M | 49.03M | 63.79M | 50.65M | 52.23M |
| Gross Profit | 243.54M | 217.88M | 186.10M | 111.72M | 83.38M | -6.62M |
| Selling, General & Admin | 99.48M | 101.79M | 172.03M | 195.04M | 196.37M | 173.54M |
| Other Operating Expenses | -22.00M | -170.00K | 1.55M | 2.48M | -1.52M | 574.00K |
| Operating Expenses | 77.48M | 101.62M | 173.58M | 197.51M | 194.85M | 174.11M |
| Operating Income | 166.06M | 116.26M | 12.52M | -85.79M | -111.47M | -180.74M |
| Interest Expense | -3.87M | -4.33M | -4.83M | -2.77M | ||
| Interest & Investment Income | 14.62M | 13.57M | 16.97M | 17.00M | 5.12M | 529.00K |
| Currency Exchange Gain (Loss) | -9.70M | -9.70M | 5.90M | -5.90M | ||
| EBT Excluding Unusual Items | 167.12M | 115.80M | 30.55M | -77.47M | -106.35M | -180.21M |
| Merger & Restructuring Charges | -1.65M | -23.11M | ||||
| Pretax Income | 167.12M | 114.16M | 7.45M | -77.47M | -106.35M | -180.21M |
| Income Tax Expense | -147.15M | -173.04M | 1.70M | 551.00K | 1.83M | 760.00K |
| Net Income | 314.27M | 287.20M | 5.75M | -78.02M | -108.18M | -180.97M |
| Net Income to Common | 314.27M | 287.20M | 5.75M | -78.02M | -108.18M | -180.97M |
| Shares Outstanding (Basic) | 131.97M | 134.37M | 143.06M | 143.24M | 141.91M | 129.37M |
| Shares Outstanding (Diluted) | 135.99M | 138.70M | 146.19M | 143.24M | 141.91M | 129.37M |
| EPS (Basic) | 2.38 | 2.14 | 0.04 | -0.54 | -0.76 | -1.40 |
| EPS (Diluted) | 2.31 | 2.07 | 0.04 | -0.54 | -0.76 | -1.40 |
| Free Cash Flow | 177.03M | 135.41M | 44.11M | -34.18M | -79.82M | -158.00M |
| Free Cash Flow Per Share | 1.30 | 0.98 | 0.30 | -0.24 | -0.56 | -1.22 |
| Gross Margin | 75.70% | 76.98% | 79.15% | 63.66% | 62.21% | -14.53% |
| Operating Margin | 51.62% | 41.07% | 5.32% | -48.88% | -83.17% | -396.31% |
| Profit Margin | 97.68% | 101.47% | 2.45% | -44.45% | -80.71% | -396.81% |
| Free Cash Flow Margin | 55.02% | 47.84% | 18.76% | -19.47% | -59.55% | -346.44% |
| EBITDA | 185.42M | 135.71M | 31.96M | -74.14M | -108.76M | -177.97M |
| EBITDA Margin | 57.63% | 47.95% | 13.59% | -42.24% | -81.15% | |
| D&A For EBITDA | 19.36M | 19.45M | 19.45M | 11.65M | 2.71M | 2.76M |
| EBIT | 166.06M | 116.26M | 12.52M | -85.79M | -111.47M | -180.74M |
| EBIT Margin | 51.62% | 41.07% | 5.32% | -48.88% | -83.17% | |
| Effective Tax Rate | 22.77% | |||||
| Revenue as Reported | 321.74M | 283.06M | 235.13M | 175.51M | 134.03M | 45.60M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 45.79M | 80.16M | 83.40M | 48.76M | 94.09M | 231.64M |
| Short-Term Investments | 440.74M | 317.78M | 275.04M | 301.61M | 295.22M | 234.18M |
| Cash & Short-Term Investments | 486.53M | 397.94M | 358.44M | 350.37M | 389.31M | 465.82M |
| Accounts Receivable | 47.41M | 41.45M | 36.54M | 24.09M | 13.48M | 15.41M |
| Other Receivables | 1.20M | 700.00K | 600.00K | 700.00K | 1.10M | |
| Receivables | 48.61M | 42.15M | 37.14M | 24.79M | 14.58M | 15.41M |
| Inventory | 43.73M | 45.69M | 39.23M | 39.70M | 24.75M | 19.33M |
| Prepaid Expenses | 5.92M | 5.75M | 11.22M | 9.49M | 13.58M | 11.71M |
| Restricted Cash | 353.00K | 53.00K | 37.00K | 120.00K | 84.00K | 257.00K |
| Other Current Assets | 2.75M | 380.00K | 529.00K | 331.00K | 234.00K | 796.00K |
| Total Current Assets | 587.89M | 491.97M | 446.60M | 424.80M | 442.54M | 513.32M |
| Property, Plant & Equipment | 63.90M | 79.57M | 98.87M | 116.57M | 8.56M | 9.80M |
| Long-Term Investments | 201.00K | |||||
| Other Intangible Assets | 3.17M | 3.76M | 4.36M | 4.98M | 6.42M | 8.40M |
| Long-Term Deferred Tax Assets | 170.65M | 176.19M | ||||
| Other Long-Term Assets | 93.00K | 93.00K | 823.00K | 1.52M | 13.34M | 11.84M |
| Total Assets | 825.70M | 751.59M | 550.64M | 548.06M | 470.86M | 543.37M |
| Accounts Payable | 3.01M | 3.31M | 5.19M | 4.33M | 3.09M | 3.88M |
| Accrued Expenses | 63.30M | 66.47M | 54.12M | 50.06M | 36.28M | 30.25M |
| Current Portion of Leases | 17.96M | 17.59M | 15.07M | 15.60M | 936.00K | 1.06M |
| Current Income Taxes Payable | 625.00K | 814.00K | ||||
| Current Unearned Revenue | 10.41M | 3.72M | 11.00M | 4.81M | 3.15M | 190.00K |
| Other Current Liabilities | 1.32M | 2.63M | 12.39M | 2.39M | 2.03M | 4.45M |
| Total Current Liabilities | 96.00M | 93.72M | 97.76M | 77.19M | 46.11M | 40.65M |
| Long-Term Leases | 40.70M | 57.22M | 64.30M | 82.01M | 7.15M | 7.68M |
| Long-Term Unearned Revenue | 7.16M | 12.65M | 1.70M | |||
| Other Long-Term Liabilities | 1.19M | 6.66M | 9.41M | 10.91M | 12.17M | 15.95M |
| Total Liabilities | 168.19M | 170.26M | 173.17M | 170.11M | 65.42M | 64.28M |
| Common Stock | 1.13B | 1.12B | 1.19B | 1.20B | 1.19B | 1.18B |
| Additional Paid-In Capital | 77.04M | 111.26M | 127.00M | 120.79M | 85.49M | 59.01M |
| Retained Earnings | -545.90M | -649.37M | -936.57M | -942.32M | -864.30M | -756.12M |
| Comprehensive Income & Other | -1.13M | -599.00K | -647.00K | -730.00K | -1.06M | -852.00K |
| Shareholders' Equity | 657.52M | 581.33M | 377.48M | 377.95M | 405.44M | 479.09M |
| Total Liabilities & Equity | 825.70M | 751.59M | 550.64M | 548.06M | 470.86M | 543.37M |
| Total Debt | 58.66M | 74.81M | 79.37M | 97.61M | 8.09M | 8.74M |
| Net Cash (Debt) | 427.86M | 323.13M | 279.07M | 252.76M | 381.22M | 457.08M |
| Net Cash Per Share | 3.15 | 2.33 | 1.91 | 1.76 | 2.69 | 3.53 |
| Filing Date Shares Outstanding | 134.00M | 132.97M | 137.34M | 144.62M | 142.58M | 141.65M |
| Total Common Shares Outstanding | 134.00M | 132.32M | 140.88M | 143.83M | 142.27M | 141.60M |
| Working Capital | 491.88M | 398.24M | 348.83M | 347.61M | 396.43M | 472.68M |
| Book Value Per Share | 4.91 | 4.39 | 2.68 | 2.63 | 2.85 | 3.38 |
| Tangible Book Value | 654.35M | 577.57M | 373.12M | 372.98M | 399.01M | 470.69M |
| Tangible Book Value Per Share | 4.88 | 4.36 | 2.65 | 2.59 | 2.80 | 3.32 |
| Machinery | 2.02M | 2.02M | 2.02M | 2.02M | 1.87M | 1.88M |
| Construction In Progress | 255.00K | 393.00K | ||||
| Leasehold Improvements | 3.24M | 3.24M | 3.24M | 3.24M | 2.98M | 2.98M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 314.27M | 287.20M | 5.75M | -78.02M | -108.18M | -180.97M |
| Depreciation & Amortization | 19.36M | 19.45M | 19.45M | 11.65M | 2.71M | 2.76M |
| Loss (Gain) From Sale of Investments | -8.48M | -10.18M | -12.73M | -12.14M | -1.57M | 660.00K |
| Stock-Based Compensation | 14.82M | 14.68M | 31.60M | 45.31M | 32.30M | 31.24M |
| Other Operating Activities | -156.31M | -166.71M | -5.12M | 5.35M | 2.03M | 10.24M |
| Change in Accounts Receivable | -16.69M | -4.91M | -12.46M | -10.61M | 1.93M | -15.41M |
| Change in Inventory | 1.06M | -6.46M | 477.00K | -15.87M | -9.07M | -5.64M |
| Change in Accounts Payable | -1.07M | -1.87M | 860.00K | 1.24M | -792.00K | 4.08M |
| Change in Unearned Revenue | 720.00K | 3.67M | 5.79M | 3.76M | 3.05M | |
| Change in Other Net Operating Assets | 9.48M | 795.00K | 10.78M | 15.86M | -1.93M | -4.65M |
| Operating Cash Flow | 177.16M | 135.66M | 44.39M | -33.46M | -79.53M | -157.69M |
| Capital Expenditures | -135.00K | -252.00K | -281.00K | -718.00K | -292.00K | -303.00K |
| Sale (Purchase) of Intangibles | -1.20M | |||||
| Investment in Securities | -154.20M | -32.52M | 39.59M | 5.88M | -59.68M | -84.53M |
| Other Investing Activities | -43.00K | -11.86M | -663.00K | -17.84M | ||
| Investing Cash Flow | -149.12M | -32.77M | 39.26M | -6.71M | -60.63M | -103.87M |
| Long-Term Debt Repaid | -13.14M | -11.99M | -10.03M | |||
| Net Debt Issued (Repaid) | -14.39M | -13.14M | -11.99M | -10.03M | ||
| Issuance of Common Stock | 71.88M | 14.95M | 9.27M | 7.17M | 3.47M | 221.11M |
| Repurchase of Common Stock | -108.88M | -107.92M | -46.37M | -2.28M | -1.04M | |
| Other Financing Activities | -3.70M | |||||
| Financing Cash Flow | -55.09M | -106.11M | -49.09M | -5.13M | 2.43M | 221.11M |
| Net Cash Flow | -27.04M | -3.22M | 34.56M | -45.30M | -137.73M | -40.45M |
| Free Cash Flow | 177.03M | 135.41M | 44.11M | -34.18M | -79.82M | -158.00M |
| Free Cash Flow Margin | 55.02% | 47.84% | 18.76% | -19.47% | -59.55% | -346.44% |
| Free Cash Flow Per Share | 1.30 | 0.98 | 0.30 | -0.24 | -0.56 | -1.22 |
| Levered Free Cash Flow | 140.48M | 91.41M | 62.94M | -3.89M | -35.10M | -98.48M |
| Unlevered Free Cash Flow | 142.90M | 94.12M | 65.96M | -2.16M | -35.10M | -98.48M |
| Cash Income Tax Paid | 2.08M | 2.82M | 2.18M | 496.00K | 1.98M | 257.00K |
| Change in Working Capital | -6.50M | -8.78M | 5.45M | -5.61M | -6.82M | -21.63M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.23B | 2.10B | 1.29B | 1.29B | 613.91M | 2.97B |
| Enterprise Value | 1.80B | 1.83B | 1.03B | 1.05B | 246.17M | 2.69B |
| Last Close Price | 16.65 | 15.95 | 8.98 | 8.99 | 4.32 | 22.87 |
| PE Ratio | 7.22 | 7.32 | 223.53 | |||
| Forward PE | 20.16 | 19.69 | 24.06 | |||
| PS Ratio | 6.93 | 7.43 | 5.47 | 7.36 | 4.58 | 65.03 |
| PB Ratio | 3.39 | 3.62 | 3.41 | 3.42 | 1.51 | 6.19 |
| P/TBV Ratio | 3.41 | 3.64 | 3.45 | 3.46 | 1.54 | 6.30 |
| P/FCF Ratio | 12.60 | 15.53 | 29.15 | |||
| P/OCF Ratio | 12.59 | 15.50 | 28.97 | |||
| EV/Sales Ratio | 5.60 | 6.46 | 4.36 | 5.97 | 1.84 | 58.94 |
| EV/EBITDA Ratio | 9.73 | 13.48 | 32.08 | |||
| EV/EBIT Ratio | 10.86 | 15.74 | 81.91 | |||
| EV/FCF Ratio | 10.19 | 13.51 | 23.25 | |||
| Debt / Equity Ratio | 0.09 | 0.13 | 0.21 | 0.26 | 0.02 | 0.02 |
| Debt / EBITDA Ratio | 0.32 | 0.55 | 2.42 | |||
| Debt / FCF Ratio | 0.33 | 0.55 | 1.80 | |||
| Net Debt / Equity Ratio | -0.65 | -0.56 | -0.74 | -0.67 | -0.94 | -0.95 |
| Net Debt / EBITDA Ratio | -2.31 | -2.38 | -8.73 | 3.41 | 3.50 | 2.57 |
| Net Debt / FCF Ratio | -2.42 | -2.39 | -6.33 | 7.39 | 4.78 | 2.89 |
| Asset Turnover | 0.48 | 0.43 | 0.43 | 0.34 | 0.26 | 0.09 |
| Inventory Turnover | 1.77 | 1.53 | 1.24 | 1.98 | 2.30 | 3.14 |
| Quick Ratio | 5.57 | 4.70 | 4.05 | 4.86 | 8.76 | 11.84 |
| Current Ratio | 6.12 | 5.25 | 4.57 | 5.50 | 9.60 | 12.63 |
| Return on Equity (ROE) | 61.42% | 59.91% | 1.52% | -19.92% | -24.46% | -40.81% |
| Return on Assets (ROA) | 15.34% | 11.16% | 1.42% | -10.53% | -13.74% | -22.43% |
| Return on Invested Capital (ROIC) | 71.33% | 65.20% | 8.65% | -114.84% | -460.30% | |
| Return on Capital Employed (ROCE) | 22.80% | 17.70% | 2.80% | -18.20% | -26.20% | -36.00% |
| Earnings Yield | 13.85% | 13.66% | 0.45% | -6.04% | -17.62% | -6.10% |
| FCF Yield | 7.93% | 6.44% | 3.43% | -2.65% | -13.00% | -5.33% |
| Buyback Yield / Dilution | 4.00% | 5.13% | -2.07% | -0.93% | -9.70% | -9.20% |